| 068760 Stock | | | KRW 53,500 100.00 0.19% |
CEO
Mr. Seo Jeong Jin was Chief Executive Officer and Director of Celltrion Pharm Inc. since January 23 2009. He also serves as Chief Executive Officer of Celltrion Inc. and Celltrion Holding Co. Ltd. He used to be Chief Executive Officer of Celltrion Healthcare Co. Ltd. and Nexol Biotech Co. Ltd. and an Advisor of Daewoo Motor Company. Seo holds a Master degree. since 2017.
| Age | 61 |
| Tenure | 8 years |
| Phone | 82 4 3717 7000 |
| Web | https://www.celltrionph.com |
Celltrion Pharm Management Efficiency
The company has return on total asset
(ROA) of
0.0341 % which means that it generated a profit of $0.0341 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.0891 %, meaning that it generated $0.0891 on every $100 dollars invested by stockholders. Celltrion Pharm's management efficiency ratios could be used to measure how well Celltrion Pharm manages its routine affairs as well as how well it operates its assets and liabilities.
Celltrion Pharm has accumulated 39.4
B in total debt with debt to equity ratio
(D/E) of 0.64, which is about average as compared to similar companies. Celltrion Pharm has a current ratio of 1.23, suggesting that it
is in a questionable position to pay out its financial obligations in time and when they become due. Debt can assist Celltrion Pharm until it has trouble settling it off, either with new capital or with free cash flow. So, Celltrion Pharm's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Celltrion Pharm sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Celltrion to invest in growth at high rates of return. When we think about Celltrion Pharm's use of debt, we should always consider it together with cash and equity.
Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju, South Korea. Celltrionph is traded on Korean Securities Dealers Automated Quotations in South Korea. Celltrion Pharm (068760) is traded on KOSDAQ in Korea and employs 29 people.
Management Performance
Celltrion Pharm Leadership Team
Elected by the shareholders, the Celltrion Pharm's board of directors comprises two types of representatives: Celltrion Pharm inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Celltrion. The board's role is to monitor Celltrion Pharm's management team and ensure that shareholders' interests are well served. Celltrion Pharm's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Celltrion Pharm's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jung Seo, Director | |
| Jungsu Seo, CEO Director | |
| Haeng Kim, Non-Executive Independent Director | |
| JongDae Yoo, Managing Director | |
| EunSuk Choi, Exec | |
| Jeong Seo, Chief Executive Officer, Director | |
| Myeong Oh, Senior Vice President | |
| SangSuk Kim, President | |
| YunHyun Kang, Managing Director | |
| Seung Choi, Managing Director | |
| Yeong Yoo, Vice President | |
| Jin Wang, Assistant Managing Director | |
| Gyeong Kim, Non-Executive Independent Director | |
| Dong Yim, Internal Auditor | |
| DongHo Woo, Exec | |
| ChangJin Kim, Managing Director | |
| Wang Lee, Non-Executive Independent Director | |
| HyukJin Gwon, Managing Director | |
Celltrion Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Celltrion Pharm a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Other Information on Investing in Celltrion Stock
Celltrion Pharm financial ratios help investors to determine whether Celltrion Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Celltrion with respect to the benefits of owning Celltrion Pharm security.